Variant report
Variant | nsv5643 |
---|---|
Chromosome Location | chr10:5229780-5302665 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:5226200-5230000 | Weak transcription | HepG2 | liver |
2 | chr10:5227200-5230800 | Enhancers | Adipose Nuclei | Adipose |
3 | chr10:5227400-5231200 | Enhancers | Liver | Liver |
4 | chr10:5227600-5230400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr10:5229600-5231000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr10:5230000-5231000 | Enhancers | HepG2 | liver |
7 | chr10:5231000-5235600 | Weak transcription | HepG2 | liver |
8 | chr10:5231200-5235600 | Weak transcription | Liver | Liver |
9 | chr10:5235600-5237600 | Enhancers | Liver | Liver |
10 | chr10:5235600-5239600 | Enhancers | HepG2 | liver |
11 | chr10:5236400-5236600 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr10:5236600-5238800 | Weak transcription | Duodenum Mucosa | Duodenum |
13 | chr10:5236800-5237000 | Enhancers | A549 | lung |
14 | chr10:5237000-5237800 | Flanking Active TSS | A549 | lung |
15 | chr10:5237000-5239800 | Enhancers | Stomach Mucosa | stomach |
16 | chr10:5237600-5237800 | Flanking Active TSS | Liver | Liver |
17 | chr10:5237600-5238000 | Enhancers | Pancreas | Pancrea |
18 | chr10:5237600-5239400 | Enhancers | Fetal Intestine Large | intestine |
19 | chr10:5237600-5239400 | Enhancers | Fetal Intestine Small | intestine |
20 | chr10:5237800-5238200 | Active TSS | Liver | Liver |
21 | chr10:5237800-5238400 | Active TSS | A549 | lung |
22 | chr10:5238000-5238400 | Weak transcription | Pancreas | Pancrea |
23 | chr10:5238200-5238800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
24 | chr10:5238200-5238800 | Flanking Active TSS | Liver | Liver |
25 | chr10:5238400-5239000 | Enhancers | Pancreas | Pancrea |
26 | chr10:5238400-5239200 | Flanking Active TSS | A549 | lung |
27 | chr10:5238600-5239000 | Enhancers | H1 Cell Line | embryonic stem cell |
28 | chr10:5238600-5239000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
29 | chr10:5238600-5239200 | Enhancers | Adipose Nuclei | Adipose |
30 | chr10:5238600-5239200 | Bivalent Enhancer | NHDF-Ad | bronchial |
31 | chr10:5238800-5239200 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
32 | chr10:5238800-5239200 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
33 | chr10:5238800-5240000 | Active TSS | Liver | Liver |
34 | chr10:5239200-5239600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
35 | chr10:5239200-5239600 | Enhancers | Duodenum Mucosa | Duodenum |
36 | chr10:5239200-5239800 | Enhancers | A549 | lung |
37 | chr10:5239600-5240000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
38 | chr10:5239600-5241000 | Weak transcription | HepG2 | liver |
39 | chr10:5239800-5240200 | Weak transcription | A549 | lung |
40 | chr10:5239800-5251800 | Weak transcription | Stomach Mucosa | stomach |
41 | chr10:5240000-5240600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
42 | chr10:5240000-5241600 | Flanking Active TSS | Liver | Liver |
43 | chr10:5240200-5240800 | Enhancers | A549 | lung |
44 | chr10:5240800-5253000 | Weak transcription | A549 | lung |
45 | chr10:5241400-5241600 | Enhancers | HepG2 | liver |
46 | chr10:5241600-5242000 | Active TSS | Liver | Liver |
47 | chr10:5242000-5242200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
48 | chr10:5242000-5242200 | Flanking Active TSS | Liver | Liver |
49 | chr10:5242200-5242800 | Genic enhancers | Liver | Liver |
50 | chr10:5242800-5244000 | Strong transcription | Liver | Liver |